🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2, open-label, monocentric, dose-escalation study of lena...
Status
Unknown
Location
Medical University of Innsbruck, Department for Internal Medicine I
Start Date
2010-03
Trial ID
NCT01166035
Treatments Being Tested
To understand the safety and efficacy of Revlimid® Capsules 2.5 mg and 5 mg...
Status
Completed
Location
ASO KK Iizuka Hospital
Start Date
2017-05-30
Trial ID
NCT03098589
Treatments Being Tested
Study Objectives 1. Evaluate the efficacy of the combination of thalidomid...
Status
Completed
Location
Weill Medical College of Cornell University
Start Date
2007-10
Trial ID
NCT00538733
Treatments Being Tested
The main purpose of REVLIMID® DUE (Drug Use Examination) is to collect and ...
Status
Completed
Location
Hallym University Sacred Heart Hospital
Start Date
2011-03-09
Trial ID
NCT02556905
Treatments Being Tested
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
This research study is evaluating a new drug called "nivolumab" as a possib...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2016-10-20
Trial ID
NCT02903381
Treatments Being Tested
Our hypothesis is that treating relapsed or refractory multiple myeloma wit...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2014-02
Trial ID
NCT02030483
Treatments Being Tested
The purpose of the study is to examine efficacy and safety of epcoritamab w...
Status
Terminated
Location
UW Cancer Center at ProHealth Care
Start Date
2023-03-06
Trial ID
NCT05660967
Treatments Being Tested
This is a study of pembrolizumab (MK-3475) in combination with lenalidomide...
Status
Terminated
Location
Multiple Locations
Start Date
2014-02-14
Trial ID
NCT02036502
Treatments Being Tested
The purpose of this study is to compare the effects, good and bad, of two w...
Status
Completed
Location
Memoral Sloan Kettering Cancer Center
Start Date
2008-12-10
Trial ID
NCT00807599
Treatments Being Tested